Medexus Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	161	101	78	39	32	63
Market Cap Growth	70.84%	28.78%	98.25%	21.95%	-48.46%	-58.62%
Enterprise Value	183	115	123	98	109	118
Last Close Price	5.10	3.12	2.42	1.61	1.60	3.14
PE Ratio	-	-	24.17	-	19.55	-
Forward PE	12.39	7.48	-	-	-	-
PS Ratio	1.16	0.73	0.50	0.26	0.22	0.65
PB Ratio	2.36	1.47	1.04	0.96	1.06	2.82
P/FCF Ratio	6.18	3.85	2.28	1.56	-	-
P/OCF Ratio	6.13	3.82	2.26	1.55	-	-
EV/Sales Ratio	1.32	0.83	0.79	0.64	0.74	1.23
EV/EBITDA Ratio	8.44	5.34	4.53	3.91	5.59	-
EV/EBIT Ratio	22.52	14.09	7.20	5.64	9.46	-
EV/FCF Ratio	7.02	4.39	3.60	3.86	-	-
Debt / Equity Ratio	0.45	0.45	0.71	1.65	3.12	3.08
Debt / EBITDA Ratio	1.43	1.43	1.95	2.68	4.81	-
Debt / FCF Ratio	1.19	1.19	1.56	2.67	-	-
Net Debt / Equity Ratio	0.32	0.32	0.25	1.47	2.54	2.52
Net Debt / EBITDA Ratio	1.02	1.02	0.70	2.42	3.97	-6.94
Net Debt / FCF Ratio	0.84	0.84	0.55	2.39	-37.88	-35.12
Asset Turnover	0.62	0.62	0.66	0.71	0.72	0.53
Inventory Turnover	0.93	0.93	1.17	1.61	1.92	1.83
Quick Ratio	0.40	0.40	0.38	0.44	0.43	0.51
Current Ratio	1.19	1.19	0.83	1.10	0.87	1.02
Return on Equity (ROE)	-4.73%	-4.73%	5.45%	-0.81%	6.07%	-16.08%
Return on Assets (ROA)	2.29%	2.29%	4.55%	5.04%	3.53%	-5.38%
Return on Invested Capital (ROIC)	9.17%	8.97%	16.99%	-33.43%	11.95%	-23.17%
Return on Capital Employed (ROCE)	6.20%	6.20%	16.00%	14.30%	10.90%	-13.60%
Earnings Yield	-2.07%	-3.32%	4.14%	-0.74%	5.12%	-5.74%
FCF Yield	16.18%	25.99%	43.91%	64.18%	-6.31%	-2.54%
Buyback Yield / Dilution	-21.91%	-21.91%	-18.76%	-8.76%	-3.36%	-30.65%